In conclusion, we screened and found MAP9 as a potential target for the treatment of human BC by mediating the TGF-β1 signaling pathway and subsequently activating G1/S transition genes and enhancing the EMT process to promote BC growth and metastasis. This evidence concerns the gene TGFB1 and breast cancer.